Dexcel Pharma
Corporate venture profile
Dexcel Pharma is the corporate venture arm of Dexcel Pharma Technologies, a pharmaceutical and biotech company. It is based in Israel. It invests from Series B to Series C+. Sectors it names: biotech and life sciences.
Every figure links to its source
Snapshot
Data behind this graphic
| Item | Value |
|---|---|
| Stage range | Series B to Series C+ |
| Sectors | Biotech and life sciences |
| Geography | Middle East and Africa |
Sources: S2 Kriya Therapeutics: USD 270m Series C announcement.
Where it invests
Key facts
| Fact | Value | Status | Source |
|---|---|---|---|
| Parent company | Dexcel Pharma Technologies | Single source | S1 |
| Parent industry | Pharmaceuticals and biotech | Single source | S1 |
| Headquarters | Israel | Single source | S1 |
| Status | Active | Single source | S1 |
| Capital source | Parent company only | Single source | S2 |
| Stages | Series B, Series C+ (inferred from announced rounds) | Estimate | S2 |
Recent rounds
Portfolio
Portfolio company named in public sources: Kriya Therapeutics.S2
Official pages
Read the firm's own pages for current information.
- Website www.dexcelpharma.com/
Sources
Disclaimer and corrections
Not affiliated. This page is not affiliated with, endorsed by or sponsored by Dexcel Pharma or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.
Spotted a mistake? Report a correction.